Transdermal Drug Delivery Lecture Notes

Lecture Objectives

  • Understand the principles of transdermal drug delivery.

  • Comprehend the skin's physiology and barrier properties relevant to drug permeation.

  • Recognize dosage form examples, their design, and clinical applications.

  • Learn the advantages and limitations of the transdermal route of administration.

  • Grasp the approaches to enhance drug delivery through the skin.

Skin Anatomy

Layers of Skin

  • Epidermis: Outer layer, primarily composed of keratinocytes.

  • Dermis: Contains connective tissue, glands, hair follicles, and blood vessels.

  • Hypodermis (Superficial Fascia): Layer of fat and connective tissue under the dermis.

Epidermis Details

  • Stratum Corneum: Outermost layer, composed of dead cells, barrier to water loss.

  • Stratum Granulosum: Contains keratinocytes that begin to lose their organelles.

  • Stratum Spinosum: Provides strength and flexibility to the skin; contains Langerhans cells.

  • Stratum Basale: Deepest layer, responsible for cell generation.

Skin Penetration Routes and Mechanisms

  • Transdermal vs. Topical Delivery:

    • Transdermal systems penetrate through the skin to achieve systemic effects.

    • Topical systems act locally on the application site.

Routes of Penetration:

  1. Transappendageal: Through hair follicles and glands.

  2. Interfacial: Through viable epidermis to dermis and bloodstream.

  3. Transcelullar: Directly through the hydrophobic membrane of skin cells.

Transdermal Drug Delivery Systems (TDDS)

Design and Function

  • Membrane-Controlled Systems: Have a reservoir of the drug, allowing controlled drug release (e.g., Estraderm, Transderm-Scop).

  • Adhesive Diffusion-Controlled Systems: Drug is dispersed within an adhesive matrix.

  • Matrix Dispersion Systems: Contain the drug in a polymer matrix which controls release.

Advantages of TDDS

  • Bypass first-pass metabolism (liver).

  • Reduced side effects and improved drug compliance.

  • Predictable drug absorption and extended therapeutic effects.

  • Suitable for patients with difficulties in oral medication.

Challenges in Drug Selection

  • Physicochemical properties: low water solubility, appropriate molecular weight.

  • The need for potent drugs with minimal irritation potential.

  • Avoid long lag times before drug reaches steady state.

Methods to Enhance Drug Delivery

  • Microneedles: Create micro-channels in the stratum corneum to facilitate delivery of larger molecules.

  • Iontophoresis: Using electrical currents to drive drugs through the skin.

  • Sonophoresis: Utilizing ultrasound to increase skin permeability.

  • Thermal and Mechanical Methods: Controlled heat and laser technologies improve drug penetration.

Released Kinetics of TDDS

  • Zero-Order Kinetics: Constant release rate - ideal (e.g., Estraderm).

  • First-Order Kinetics: Release rate depends on the concentration of drug (e.g., Nitrodisc).

Marketed Transdermal Products

Examples

  • Scopolamine: Motion sickness.

  • Fentanyl: Chronic pain management.

  • Ortho-Evra: Contraceptive patch.

Future Prospects of Transdermal Delivery

  • Innovations focusing on ease of use and effective dosing.

  • Adoption of microfabricated systems for controlled drug release.

  • Development of hybrid delivery systems integrating various technologies for better patient compliance.

Conclusion

Transdermals play an important role in drug delivery, providing an effective mechanism for systemic treatment while overcoming limitations of oral dosing. Continuous innovation in technology is essential to enhance delivery efficacy and patient experience.